MAPT and supranuclear palsy, progressive, 1: This was observed, for example, when transgenic mice were injected with either PSP or CBD human brain homogenate, the specific astrocytic features mentioned in Box 3 in PSP vs CBD were observed in mouse brain tissues [144], indicating that using this type of approach can be used to model neuropathological aspects of disease and be utilised to assess treatments targeting the toxic aggregation of tau or aS.